Stories / Global Impact

A novel therapy may free some transplant patients from having to take immunosuppressant drugs for...

Stories / Hope

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's...

Stories / Global Impact

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to...

Explore Novartis

Recent Updates

Featured / 21 Jul

Novartis announces second quarter results

Novartis delivered solid performance and strong pipeline progress with major approvals and key launches.

16 years researching musculoskeletal disease equips our scientist for linchpin role in #drugdevelopment http://t.co/olsvJScLYk #careers 6 hours 18 min ago
Our Business

Novartis focuses its business on three leading divisions with strong innovation power and global scale: pharmaceuticals, eye care and generics.